Research into an enzyme that produces a hormone released
after sex has inspired Australian National University chemists to
create new treatments for small-cell lung cancer.
Led by Professor Chris Easton and PhD student Ms. Lucy Cao from the
ARC Centre of Excellence for Free Radical Chemistry and Biotechnology at
ANU, the team are working to reduce the number of small-cell lung cancer
deaths by building new drugs that target the biology underlying the
disease. Their work has been published in the latest edition of The
Royal Society Chemistry journal, Medicinal Chemistry Communications.
“Given that one in every 28 Australians are diagnosed with lung cancer and it is the most common cause of cancer death, there is a real need to develop new pharmaceuticals to treat this disease. Although it is still early days our results are very promising,” said Professor Easton.
The team are investigating an enzyme, known as PAM, which activates a number of important peptide hormones. These include calcitonin, which promotes cell proliferation, and oxytocin, dubbed the ‘love hormone’, as it produces feelings of contentment following orgasm. Imbalances in peptide hormones have been shown to cause inflammatory diseases, asthma, and various cancers.
“Given that one in every 28 Australians are diagnosed with lung cancer and it is the most common cause of cancer death, there is a real need to develop new pharmaceuticals to treat this disease. Although it is still early days our results are very promising,” said Professor Easton.
The team are investigating an enzyme, known as PAM, which activates a number of important peptide hormones. These include calcitonin, which promotes cell proliferation, and oxytocin, dubbed the ‘love hormone’, as it produces feelings of contentment following orgasm. Imbalances in peptide hormones have been shown to cause inflammatory diseases, asthma, and various cancers.
Thanks for your great sharing! ^_^
ReplyDeleteA lot of research still needs to be done in the field of Lung Cancer Treatment .
ReplyDelete